Perrigo Co. plc, of Dublin, said it settled the Hatch-Waxman litigation relating to acne product Onexton Gel (clindamycin phosphate 1.2 percent and benzoyl peroxide 3.75 percent) brought by Valeant Pharmaceuticals North America LLC and Dow Pharmaceutical Sciences Inc.